Login / Signup

Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC).

Alain VergnenegreChristos Chouaid
Published in: Expert review of pharmacoeconomics & outcomes research (2018)
Drug costs are one of the major challenges of LC management. The multiplication of medical-economic analyses will assure better access to the marketing of these new and expensive therapeutic agents, but also to the selection of the best management strategy for these cancers.
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • mass spectrometry
  • combination therapy
  • young adults
  • life cycle
  • replacement therapy
  • drug induced
  • tyrosine kinase
  • high resolution mass spectrometry